QIAGEN announced the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against t...
Sandoz, a global leader in generic and biosimilar medicines, is pleased to announce the European Commission's (EC) approval of Pyzchiva® (biosimilar us...
SNIPR Biome ApS (“SNIPR”), the company pioneering the development of precision medicines using CRISPR technology for microbial gene the...
Designed to run seamlessly on the BioCode® MDx-3000 system, this multiplex nucleic acid amplification test delivers unparalleled accuracy in id...
This expansion comes in the wake of regulatory approval granted last October by Anvisa, the Brazilian health regulatory authority, for EFA's groundbreaking...
Agilent Technologies , a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC Sa...
Incyte and China Medical System Holdings Limited are pleased to announce that on March 31, 2024, Incyte and CMS, through a wholly-owned dermatology m...
Game-changing continuous-batch production of RNA service removes process development and scale-up steps through automation and significantly cuts clinical ...
Nucleus Genomics, a pioneering genetic testing and analysis company, announced the debut of its DNA analysis product, marking a significant...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotechnology company focused on the development of novel antibody the...
Gilles Besin, Ph.D., CSO at Orbital: “Elegen's unique expertise in supplying...IVT-ready synthetic DNA constructs is very attractive ...
Matthias Heinzel, Member of the Executive Board of Merck and CEO Life Science, emphasized the strategic importance of this move, stating, "The Asia...
Samsung Ventures, a key player in the life sciences sector, has made a strategic investment in BrickBio, Inc., a preclinical-stage biopharmaceutical compan...
Biocon Biologics Limited, a fully integrated global biosimilars company and a subsidiary of Biocon Limited (BSE code: 532523, NSE: BIOCON),...
© 2025 Biopharma Boardroom. All Rights Reserved.
